Tot Tibor
Department of Pathology and Clinical Cytology, Central Hospital Falun, 791 82, Falun, Sweden.
Int J Breast Cancer. 2012;2012:395415. doi: 10.1155/2012/395415. Epub 2012 Oct 21.
Breast cancer subgross morphological parameters (disease extent, lesion distribution, and tumor size) provide significant prognostic information and guide therapeutic decisions. Modern multimodality radiological imaging can determine these parameters with increasing accuracy in most patients. Large-format histopathology preserves the spatial relationship of the tumor components and their relationship to the resection margins and has clear advantages over traditional routine pathology techniques. We report a series of 1000 consecutive breast cancer cases worked up with large-format histology with detailed radiological-pathological correlation. We confirmed that breast carcinomas often exhibit complex subgross morphology in both early and advanced stages. Half of the cases were extensive tumors and occupied a tissue space ≥40 mm in its largest dimension. Because both in situ and invasive tumor components may exhibit unifocal, multifocal, and diffuse lesion distribution, 17 different breast cancer growth patterns can be observed. Combining in situ and invasive tumor components, most cases fall into three aggregate growth patterns: unifocal (36%), multifocal (35%), and diffuse (28%). Large-format histology categories of tumor size and disease extent were concordant with radiological measurements in approximately 80% of the cases. Noncalcified, low-grade in situ foci, and invasive tumor foci <5 mm were the most frequent causes of discrepant findings.
乳腺癌大体形态学参数(疾病范围、病灶分布和肿瘤大小)可提供重要的预后信息并指导治疗决策。现代多模态放射影像学能够在大多数患者中越来越准确地确定这些参数。大切片组织病理学保留了肿瘤成分的空间关系及其与手术切缘的关系,与传统常规病理技术相比具有明显优势。我们报告了一系列连续1000例乳腺癌病例,采用大切片组织学进行检查,并进行了详细的放射学-病理学相关性分析。我们证实,乳腺癌在早期和晚期通常都表现出复杂的大体形态。一半的病例为广泛肿瘤,其最大径占据的组织空间≥40毫米。由于原位癌和浸润性癌成分均可表现为单灶性、多灶性和弥漫性病灶分布,因此可观察到17种不同的乳腺癌生长模式。结合原位癌和浸润性癌成分,大多数病例可归为三种总体生长模式:单灶性(36%)、多灶性(35%)和弥漫性(28%)。在大约80%的病例中,肿瘤大小和疾病范围的大切片组织学分类与放射学测量结果一致。非钙化、低级别原位病灶以及直径<5毫米的浸润性癌病灶是导致结果不一致的最常见原因。